Correlation of peripheral arterial blood flow with plasma chemerin and VEGF in diabetic peripheral vascular disease

Biomarkers in Medicine

Volumn 6, Issue 1, 2012, Pages 81-87

  Zakareia, Faten Abdulhady ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b NONE   (Saudi Arabia)

Author keywords

ankle brachial index; chemerin; diabetic peripheral vasculopathy; microangiopathy; VEGF

Indexed keywords

ADIPOCYTOKINE; CHEMERIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; UNCLASSIFIED DRUG; UREA; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ANKLE BRACHIAL INDEX; ARTERY BLOOD FLOW; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; UPREGULATION;

EID: 84856603282     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.11.85     Document Type: Article

References (24)

1. Chen LL, Yu F, Zeng TS, Liao YF, Li YM, Ding HC. Effects of gliclazide on endothelial function in patients with newly diagnosed Type 2 diabetes. Eur. J. Pharmacol. 659(2-3), 296-301 (2011).
2. Dobarro D, Gómez-Rubn MC, Sanchez-Recalde A, et al. Current pharmacological approach to restore endothelial dysfunction. Cardiovasc. Hematol. Agents Med. Chem. 7(3), 212-222 (2009).
3. Jennifer LH, Christian MM, Xiaohong WH. Gibbons hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. Circulation Res. 87, 574 (2000).
4. Yu T, Sheu SS, Robotham JL, Yoon Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc. Res. 79(2), 341-351 (2008). (Pubitemid 351951612)
5. Fatehi-Hassanabad Z, Chan CB, Furman BL. Reactive oxygen species and endothelial function in diabetes. Eur. J. Pharmacol. 636(1-3), 8-17 (2010).
6. Bozaoglu K, Curran JE, Stocker CJ, et al. Chemerin, a novel adipokine in the regulation of angiogenesis. J. Clin. Endocrinol. Metab. 95(5), 2476-2485 (2010).
7. Yamamoto T, Qureshi AR, Anderstam B, et al. Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol. Dial. Transplant. 25(12), 4017-4023 (2010).
8. Yang M, Yang G, Dong J, et al. Elevated plasma levels of chemerin in newly diagnosed Type 2 diabetes mellitus with hypertension. J. Invest. Med. 58(7), 883-886 (2010).
9. Klöting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 299(3), E506-E515 (2010).
10. Bosch-Marcé M, Pola R, Wecker AB, et al. Hyperhomocysteinemia impairs angiogenesis in a murine model of limb ischemia. Vasc. Med. 10(1), 15-22 (2005). (Pubitemid 40667581)
11. Quattrini C, Jeziorska M, Boulton AJ, Malik RA. Reduced vascular endothelial growth factor expression and intra-epidermal nerve fibre loss in human diabetic neuropathy. Diabet. Care 31(1), 140-145 (2008).
12. Kirchmair R, Tietz AB, Panagiotou E, et al. Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF. Mol. Ther. 15(1), 69-75 (2007). (Pubitemid 46043651)
13. Dong X, Wang YS, Dou GR, et al. Influence of Dll4 via HIF-1a-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions. PLoS ONE 6(4), e18481 (2011).
14. Purroy F, Coll B, Oró M, et al. Predictive value of ankle brachial index in patients with acute ischaemic stroke. Eur. J. Neurol. 17(4), 602-606 (2009).
15. Fowkes FG, Price JF, Stewart MC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 303(9), 841-848 (2010).
16. Varley H. Practical Clinical Biochemistry (6th Edition). Heinemann Medical Books, London, UK (1998).
17. Burtis CA, Ashwood ER. Teitz Textbook of Clinical Chemistry (2nd Edition). WB Saunders Company, PA, USA (1994).
18. Zakareia FA, Al-Drees AA, Al-Regaiy KA, Alrouq FA. Correlation of electroretinography b-wave absolute latency, plasma levels of human basic fibroblast growth factor, vascular endothelial growth factor, fatty acid synthase and adrenomedullin in diabetic retinopathy. J. Diabet. Complicat. 24(3), 179-185 (2010).
19. Michael L, Alexander B, Martin G, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur. J. Endocrinol. 161(2), 339-344 (2009).
20. Kaur J, Adya R, Tan BK, Chen J, Randeva HS. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem. Biophys. Res. Commun. 391(4), 1762-1768 (2010).
21. Mahdy RA, Nada WM. Evaluation of the role of vascular endothelial growth factor in diabetic retinopathy. Ophthalmic Res. 45(2), 87-91 (2011).
22. Wirostko B, Wong TY, Simó R. Vascular endothelial growth factor and diabetic complications. Progress Retinal Eye Res. 27(6), 608-621 (2008).
23. Kolostova K, Taltynov O, Pinterova D, et al. Wound healing gene therapy: cartilage regeneration induced by vascular endothelial growth factor plasmid. Am. J. Otolaryngol. 33(1), 68-74 (2011).
24. Saito D, Maeshima Y, Nasu T, et al. Amelioration of renal alterations in obese Type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis. Am. J. Physiol. Renal. Physiol. 300(4), F873-F886 (2011).